Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 182,394 | 171,836 | 178,105 | 180,556 | 145,712 |
| Cost of Goods | 87,228 | 81,736 | 81,965 | 72,153 | 72,974 |
| Gross Profit | 95,166 | 90,100 | 96,140 | 108,403 | 72,738 |
| Operating Expenses | 40,177 | 42,826 | 43,125 | 35,878 | 36,816 |
| Operating Income | 55,217 | 48,010 | 53,980 | 72,678 | 36,896 |
| Interest Expense | 8,609 | 8,611 | 9,456 | 13,702 | 3,602 |
| Other Income | 3,635 | 7,904 | -3,684 | 4,271 | -787 |
| Pre-tax Income | 50,243 | 47,303 | 40,840 | 63,247 | 32,507 |
| Income Tax | 12,294 | 4,126 | 4,673 | 14,025 | 6,383 |
| Net Income Continuous | 37,949 | 43,177 | 36,167 | 49,222 | 26,124 |
| Net Income | $37,949 | $43,177 | $36,167 | $49,222 | $26,124 |
| EPS Basic Total Ops | 0.77 | 0.90 | 0.76 | 1.01 | 0.54 |
| EPS Basic Continuous Ops | 0.78 | 0.90 | 0.76 | 1.01 | 0.54 |
| EPS Diluted Total Ops | 0.73 | 0.81 | 0.70 | 0.91 | 0.49 |
| EPS Diluted Continuous Ops | 0.73 | 0.81 | 0.69 | 0.91 | 0.49 |
| EPS Diluted Before Non-Recurring Items | 0.85 | 0.93 | 0.81 | 1.08 | 0.58 |
| EBITDA(a) | $70,801 | $63,121 | $69,718 | $90,533 | $46,185 |